Category: Omicron VoC (10 publications)

Publications

Primary: Shown in the list of current labels.

Year 2022

DOI Crossref

Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron

Gao Y, Cai C, Grifoni A, ..., Aleman S, Buggert M

Nat Med - (-) - [2022-01-14; online 2022-01-14]

Category: Biochemistry Category: Health Category: Omicron VoC Research Area: Vaccine Type: Journal article

DOI Crossref

Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants

Neamtu A, Mocci F, Laaksonen A, Barroso da Silva FL

bioRxiv - (-) - [2022-01-05; online 2022-01-05]

Category: Omicron VoC Type: Preprint

DOI Crossref

Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant

Zuo F, Abolhassani H, Du L, ..., Marcotte H, Pan-Hammarström Q

medRxiv - (-) - [2022-01-05; online 2022-01-05]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint

DOI Crossref

Structural basis of Omicron neutralization by affinity-matured public antibodies

Sheward DJ, Pushparaj P, Das H, ..., Karlsson Hedestam GB, Hällberg BM

bioRxiv - (-) - [2022-01-04; online 2022-01-04]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint

DOI Crossref

Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron (B.1.1.529)

Gao Y, Cai C, Grifoni A, ..., Aleman S, Buggert M

Research Square - (-) - [2022-01-03; online 2022-01-03]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint

Year 2021

DOI Crossref

Clinical grade ACE2 effectively inhibits SARS-CoV-2 Omicron infections

Monteil V, Stephanie D, Klingström J, ..., Penninger JM, Mirazimi A

bioRxiv - (-) - [2021-12-27; online 2021-12-27]

Category: Biochemistry Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab Research Area: Host cell systems biology and targets Type: Preprint

DOI Crossref

Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics

Almazán NM, Rahbar A, Carlsson M, ..., Sörensen B, Söderberg-Nauclér C

medRxiv - (-) - [2021-12-25; online 2021-12-25]

Category: Genomics & transcriptomics Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Preprint

DOI Crossref

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

Sheward DJ, Kim C, Ehling RA, ..., Albert J, Murrell B

bioRxiv - (-) - [2021-12-20; online 2021-12-20]

Category: Omicron VoC Type: Preprint

PubMed DOI Crossref

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies.

Kannan SR, Spratt AN, Sharma K, ..., Byrareddy SN, Singh K

J Autoimmun 126 (-) 102779 [2021-12-13; online 2021-12-13]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Journal article

DOI Crossref

Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Schubert M, Bertoglio F, Steinke S, ..., Čičin-Šain L, Hust M

medRxiv - (-) - [2021-12-13; online 2021-12-13]

Category: Biochemistry Category: Health Category: Omicron VoC Type: Preprint